Lagging Cancer Diagnoses Pose Threat to Progress Made in ​Cancer Related Deaths

Returning guest, Dr. Harvey Kaufman,​ MD, FCAP,​ Senior Medical Director, Medical Informatics at Quest Diagnostics, the world’s leading provider of diagnostic information services, discusses a new Quest Diagnostics Health Trends study, published in the Journal of Clinical Oncology, which shows that diagnosis of the two most common cancers – breast and prostate – remains down from pre-pandemic levels (17% and 11% respectively). This suggests people are still delaying preventative care, missing annual screenings, and could be living with unknown cancers, potentially leading to diagnosis at more advanced stages of the disease and higher rates of morbidity and death.

Dr. Harvey Kaufman is a Senior Medical Director, Medical Informatics at Quest Diagnostics. In that capacity, Harvey leads the Information Ventures health informatics analyst team. He also leads Quest’s Health Trends efforts. Harvey joined the company in 1992 as Medical Director in Cambridge, Massachusetts. He was the first Chief Laboratory Officer for Quest Diagnostics, the first Six Sigma Quality leader, and the first medical director of Hospital Services, Business Development, International and Clinical Trials, as well as Health and Wellness. Harvey has been involved with Quest Diagnostics Health Trends™ since its inception in 2005 and has provided medical support for many of our informatics activities.